Spero Therapeutics (SPRO) Short Interest Ratio & Short Volume $0.83 -0.01 (-0.68%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.80 -0.03 (-3.37%) As of 02/21/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Spero Therapeutics Short Interest DataSpero Therapeutics (SPRO) has a short interest of 376,800 shares. This marks a 6.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.5, indicating that it would take 1.5 days of the average trading volume of 216,602 shares to cover all short positions.Current Short Interest376,800 sharesPrevious Short Interest354,100 sharesChange Vs. Previous Month+6.41%Dollar Volume Sold Short$322,766.88Short Interest Ratio1.5 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares54,520,000 sharesPercentage of Shares Shorted0.69%Today's Trading Volume82,071 sharesAverage Trading Volume216,602 sharesToday's Volume Vs. Average38% Short Selling Spero Therapeutics? Sign up to receive the latest short interest report for Spero Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSPRO Short Interest Over TimeSPRO Days to Cover Over TimeSPRO Percentage of Float Shorted Over Time Spero Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2025376,800 shares $322,766.88 +6.4%N/A1.5 $0.86 1/15/2025354,100 shares $317,698.52 -14.2%N/A1.2 $0.90 12/31/2024412,600 shares $424,978.00 -8.6%N/A1.4 $1.03 12/15/2024451,200 shares $482,784.00 -8.6%N/A1.7 $1.07 11/30/2024493,800 shares $562,932.00 -9.7%N/A2 $1.14 11/15/2024546,800 shares $645,224.00 -12.5%N/A2.3 $1.18 10/31/2024625,200 shares $768,996.00 +61.5%N/A3 $1.23 10/15/2024387,100 shares $464,520.00 +0.7%N/A3.2 $1.20 9/30/2024384,300 shares $514,962.00 -0.2%N/A3 $1.34 9/15/2024385,200 shares $527,724.00 -5.8%N/A3.4 $1.37 Get the Latest News and Ratings for SPRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024409,100 shares $560,467.00 +8.6%N/A3.1 $1.37 8/15/2024376,700 shares $455,807.00 +5.8%N/A2.9 $1.21 7/31/2024355,900 shares $501,819.00 -8.8%N/A2.6 $1.41 7/15/2024390,300 shares $563,983.50 -7.1%N/A2.7 $1.45 6/30/2024420,000 shares $546,000.00 -3.3%N/A2.5 $1.30 6/15/2024434,200 shares $590,512.00 -10.3%N/A2.3 $1.36 5/31/2024483,900 shares $687,138.00 -2.1%N/A1.7 $1.42 5/15/2024494,200 shares $800,604.00 +5.6%N/A1.6 $1.62 4/30/2024468,100 shares $664,702.00 -8.8%N/A1.5 $1.42 4/15/2024513,200 shares $785,196.00 -21.5%N/A1.6 $1.53 3/31/2024653,800 shares $1.12 million +6.5%N/A2.1 $1.72 3/15/2024613,900 shares $1.10 million +8.9%N/A2 $1.79 2/29/2024564,000 shares $930,600.00 -8.9%N/A2.8 $1.65 2/15/2024619,000 shares $940,880.00 -12.5%N/A3.2 $1.52 1/31/2024707,100 shares $1.07 million +4.0%N/A3.8 $1.52 1/15/2024680,200 shares $986,290.00 -13.8%N/A4 $1.45 12/31/2023789,000 shares $1.16 million -19.2%N/A4.5 $1.47 12/15/2023976,500 shares $1.26 million -9.6%N/A6 $1.29 11/30/20231,080,000 shares $1.23 million -4.4%N/A6.2 $1.14 11/15/20231,130,000 shares $1.29 million -10.3%N/A4.7 $1.14 10/31/20231,260,000 shares $1.36 million -3.1%N/A4.8 $1.08 10/15/20231,300,000 shares $1.47 million -3.7%N/A4.1 $1.13 9/30/20231,350,000 shares $1.63 million -5.6%N/A4.2 $1.21 9/15/20231,430,000 shares $1.83 million +25.4%N/A4.3 $1.28 8/31/20231,140,000 shares $1.71 million No ChangeN/A3.2 $1.50 8/15/20231,140,000 shares $1.53 million -2.6%N/A3.8 $1.35 7/31/20231,170,000 shares $1.91 million No ChangeN/A3.9 $1.63 7/15/20231,170,000 shares $1.77 million -4.9%N/A4.2 $1.51 6/30/20231,230,000 shares $1.78 million +40.4%N/A4 $1.45 6/15/2023876,300 shares $1.38 million -0.6%N/A1.8 $1.57$5,000 DOGE check? (Ad)Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.Everything you need to know is right here. 5/31/2023881,800 shares $1.53 million -9.5%N/A1.7 $1.74 5/15/2023974,400 shares $1.82 million -32.8%N/A1.7 $1.87 4/30/20231,450,000 shares $2.57 million -21.6%N/A2.5 $1.77 4/15/20231,850,000 shares $3.18 million +17.1%N/A3.3 $1.72 3/31/20231,580,000 shares $2.29 million +67.6%N/A2.8 $1.45 3/15/2023942,700 shares $1.39 million +142.0%N/A2.1 $1.47 2/28/2023389,500 shares $576,460.00 +35.5%N/A0.9 $1.48 2/15/2023287,400 shares $514,446.00 -38.6%N/A0.7 $1.79 1/31/2023468,200 shares $866,170.00 -29.9%N/A0.8 $1.85 1/15/2023667,900 shares $1.34 million -21.4%N/A1.1 $2.00 12/30/2022849,400 shares $1.47 million -14.6%N/A1.1 $1.73 12/15/2022994,200 shares $1.69 million -23.5%N/A0.4 $1.70 11/30/20221,300,000 shares $2.52 million -13.9%N/A0.2 $1.94 11/15/20221,510,000 shares $2.84 million +22.8%5.5%0.2 $1.88 10/31/20221,230,000 shares $2.41 million -15.8%4.5%0.2 $1.96 10/15/20221,460,000 shares $2.89 million -32.4%5.4%0.2 $1.98 9/30/20222,160,000 shares $4.32 million +177.9%8.0%0.3 $2.00 9/15/2022777,200 shares $753,884.00 +182.0%2.9%0.1 $0.97 8/31/2022275,600 shares $222,381.64 -32.9%1.0%0.1 $0.81 8/15/2022410,600 shares $371,059.22 +1.1%1.5%1.3 $0.90 7/31/2022406,100 shares $297,346.42 -27.2%1.6%1.1 $0.73 7/15/2022557,800 shares $440,662.00 +34.9%2.3%0.8 $0.79 6/30/2022413,600 shares $306,477.60 -70.9%1.7%0.6 $0.74 6/15/20221,420,000 shares $1.36 million -9.0%5.8%1.9 $0.96 5/31/20221,560,000 shares $1.84 million -5.5%6.4%2.3 $1.18 5/15/20221,650,000 shares $2.82 million -55.3%6.8%2.6 $1.71 4/30/20223,690,000 shares $17.93 million +6.7%14.6%6.3 $4.86 4/15/20223,460,000 shares $21.14 million +6.5%13.7%16.7 $6.11 3/31/20223,250,000 shares $28.28 million +4.2%13.1%16.5 $8.70 3/15/20223,120,000 shares $25.40 million +5.4%12.6%18.6 $8.14 2/28/20222,960,000 shares $28.42 million +5.7%11.9%20.8 $9.60 2/15/20222,800,000 shares $27.94 million +12.0%11.3%19.6 $9.98 1/31/20222,500,000 shares $29.68 million +4.6%10.1%18.6 $11.87 1/15/20222,390,000 shares $31.55 million +4.4%9.4%21.1 $13.20 12/31/20212,290,000 shares $36.66 million -1.7%9.0%23.2 $16.01 12/15/20212,330,000 shares $30.64 million -0.9%9.2%24.5 $13.15 11/30/20212,350,000 shares $33.49 million -2.5%9.3%23.9 $14.25 11/15/20212,410,000 shares $39.55 million -3.6%9.5%22.4 $16.41 10/29/20212,500,000 shares $43.90 million No Change9.9%21 $17.56 10/15/20212,500,000 shares $42.55 million -1.2%9.9%21.4 $17.02 9/30/20212,530,000 shares $46.58 million -1.9%10.0%20.4 $18.41 9/15/20212,580,000 shares $47.81 million -4.1%10.2%16.4 $18.53 8/31/20212,690,000 shares $51.78 million +1.9%10.9%15.8 $19.25 8/13/20212,640,000 shares $35.69 million No Change10.7%16.5 $13.52 7/30/20212,640,000 shares $35.22 million No Change11.6%17 $13.34 7/15/20212,640,000 shares $37.73 million +10.0%12.1%16.6 $14.29 6/30/20212,400,000 shares $33.50 million -23.1%9.9%14.5 $13.96 6/15/20213,120,000 shares $47.55 million -1.0%12.9%22.1 $15.24 5/28/20213,150,000 shares $45.68 million -3.4%13.0%20.3 $14.50 5/14/20213,260,000 shares $42.28 million -2.1%N/A19.9 $12.97$5,000 DOGE check? (Ad)Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.Everything you need to know is right here. 4/30/20213,330,000 shares $45.59 million -2.1%N/A17.5 $13.69 4/15/20213,400,000 shares $44.81 million +0.6%N/A14 $13.18 3/31/20213,380,000 shares $46.04 million +50.9%N/A12.9 $13.62 3/15/20212,240,000 shares $37.50 million +1.8%N/A6.7 $16.74 2/26/20212,200,000 shares $40.44 million -1.8%N/A6.6 $18.38 2/12/20212,240,000 shares $45.52 million -0.4%N/A6.6 $20.32 1/29/20212,250,000 shares $40.95 million +0.9%N/A6.4 $18.20 1/15/20212,230,000 shares $37.08 million -0.9%N/A7.3 $16.63 12/31/20202,250,000 shares $45.52 million +17.8%N/A7.3 $20.23 12/15/20201,910,000 shares $34.02 million -2.1%N/A6.2 $17.81 11/30/20201,950,000 shares $32.62 million +1.6%N/A5.9 $16.73 11/15/20201,920,000 shares $27.49 million +2.7%N/A5 $14.32 10/30/20201,870,000 shares $25.13 million +3.3%N/A5.1 $13.44 10/15/20201,810,000 shares $24.63 million +1.7%N/A5.2 $13.61 9/30/20201,780,000 shares $19.86 million -6.3%N/A5.4 $11.16 9/15/20201,900,000 shares $18.98 million +49.6%N/A6.4 $9.99 8/31/20201,270,000 shares $13.80 million +18.7%8.5%5.3 $10.87 8/14/20201,070,000 shares $13.38 million +2.9%7.2%6.7 $12.50 7/31/20201,040,000 shares $12.17 million +8.0%7.0%6.2 $11.70 7/15/2020963,100 shares $12.96 million +11.1%6.7%5 $13.46 6/30/2020866,900 shares $11.49 million +39.1%6.0%4.6 $13.25 6/15/2020623,200 shares $7.45 million +8.0%4.3%3.7 $11.95 5/29/2020577,300 shares $6.82 million -0.9%4.0%3.6 $11.82 5/15/2020582,300 shares $6.95 million +5.1%4.1%3.9 $11.93 4/30/2020554,300 shares $6.68 million +3.2%3.9%4.2 $12.06 4/15/2020536,900 shares $4.17 million +6.5%3.8%5.2 $7.76 3/31/2020504,100 shares $4.34 million +18.9%3.9%5.1 $8.60 3/13/2020424,100 shares $3.35 million -3.6%3.0%4.6 $7.91 2/28/2020439,800 shares $2.61 million -42.5%3.1%5.1 $5.93 SPRO Short Interest - Frequently Asked Questions What is Spero Therapeutics' current short interest? Short interest is the volume of Spero Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 376,800 shares of SPRO short. Learn More on Spero Therapeutics' current short interest. What is a good short interest ratio for Spero Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPRO shares currently have a short interest ratio of 2.0. Learn More on Spero Therapeutics's short interest ratio. Which institutional investors are shorting Spero Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Spero Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Spero Therapeutics' short interest increasing or decreasing? Spero Therapeutics saw a increase in short interest in January. As of January 31st, there was short interest totaling 376,800 shares, an increase of 6.4% from the previous total of 354,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Spero Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Spero Therapeutics: ProQR Therapeutics (1.13%), Aclaris Therapeutics, Inc. (5.49%), scPharmaceuticals Inc. (11.21%), Lyell Immunopharma, Inc. (7.64%), Alector, Inc. (7.25%), Innate Pharma S.A. (0.18%), Greenwich LifeSciences, Inc. (10.90%), MacroGenics, Inc. (9.40%), Genelux Co. (6.23%), Checkpoint Therapeutics, Inc. (21.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Spero Therapeutics stock? Short selling SPRO is an investing strategy that aims to generate trading profit from Spero Therapeutics as its price is falling. SPRO shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Spero Therapeutics? A short squeeze for Spero Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRO, which in turn drives the price of the stock up even further. How often is Spero Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRO, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies ProQR Therapeutics Short Interest Aclaris Therapeutics Short Interest scPharmaceuticals Short Interest Lyell Immunopharma Short Interest Alector Short Interest Innate Pharma Short Interest Greenwich LifeSciences Short Interest MacroGenics Short Interest Genelux Short Interest Checkpoint Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SPRO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
